Clinical trial
Poznan Prospective Study of Type 1 Diabetic Patients Treated With Intensive Insulin Therapy From the Onset of the Disease.
NCT01411033 is registered in ClinicalTrials.gov with Poznan University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Poznan Prospective Study of Type 1 Diabetic Patients Treated With Intensive Insulin Therapy From the Onset of the Disease.
- Lead sponsor
- Poznan University of Medical Sciences
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- January 31, 1994
- Completion date
- December 31, 2028
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
insulin resistance, insulin treatment overcorrection, macroangiopathy, microangiopathy